Determinants of glycemic control and quality of life in type 2 diabetic patients

Latin American Journal of Pharmacy

Volumn 30, Issue 5, 2011, Pages 860-867

  Souza, Rodrigo A P ^a   Correr, Cassyano J ^a   Melchiors, Ana C ^a   Sanches, Andréia C ^a   Wiens, Astrid ^a   Pontarolo, Roberto ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Diabetes complications; Diabetes mellitus; Glycemic control; Quality of life; Treatment compliance

Indexed keywords

ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; ISOPHANE INSULIN; METFORMIN;

ABDOMINAL CIRCUMFERENCE; ADULT; AGE; ANTHROPOMETRY; ARTICLE; BODY MASS; CEREBROVASCULAR DISEASE; COMBINATION CHEMOTHERAPY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DIABETES QUALITY OF LIFE SCORE; DIABETIC FOOT; DIABETIC NEUROPATHY; DRUG USE; EDUCATIONAL STATUS; EXPLORATORY RESEARCH; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICATION REGIMEN COMPLEXITY INDEX; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTTINGHAM HEALTH PROFILE; PATIENT COMPLIANCE; PERIPHERAL VASCULAR DISEASE; QUALITY OF LIFE; QUESTIONNAIRE; RACE; SCORING SYSTEM; VISUAL IMPAIRMENT;

EID: 79959519571     PISSN: 03262383     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. World Health Organization (2007) Available at: http://www.who.int/mediacentre/factsheets/fs312/en/index.html [Acessed 16 maio 2007]
2. Barcelo, A., C. Aedo, S. Rajpathak & S. Robles (2003) Bull. World Health Organ. 81: 19-27.
3. Sociedade Brasileira De Diabetes (2007) Tratamento e acompanhamento do diabetes mellitus - Diretrizes da Sociedade Brasileira de Diabetes, Diagraphic, Rio de Janeiro.
4. Nathan, D.M. (1993) N. Engl. J. Med. 328: 1676-85.
5. Fincke, B.G., J.A. Clark, M. Linzer, A. Spiro 3rd, D.R. Miller, A. Lee et al. (2005) J. Ambul. Care Manage. 28: 262-73.
6. The Ukdps Group (1998) Lancet 352: 837-53.
7. Holmes, J., S. Mcgill, P. Kind, J. Bottomley, S. Gillam & M. Murphy (2000) Value Health 3 (Suppl 1): 47-51.
8. Assuncao, M.C., I.S. Santos & N.C. Valle (2005) Rev. Saude Publica 39: 183-90.
9. Dominguez, B.C. (2007) Radis 59: 11.
10. The WHOQOL Group (1994) "The development of the World Health Organization quality of life assessment instrument (the WHOQOL)", in Quality of life assessment: international perspectives" (J. Orley &W. Kuyken), Springer Verlag, Heidelberg, pp. 41-60.
11. Fleck, M.P., S. Louzada, M. Xavier, E. Chachamovich, G. Vieira, L. Santos et al. (1999) Rev Saude Publica 33: 198-205.
12. American Diabetes Association (2008) Diabetes Care 31 (Suppl 1): S12-54.
13. Correr, C.J., R. Pontarolo, A.C. Melchiors, P. Rossignoli, F. Fernandez-Llimos & R.B. Radominski (2008) Arq. Bras. Endocrinol. Metabol. 52: 515-22.
14. Teixeira-Salmela, L.F., Lde C. Magalhaes, A.C. Souza, M de C. Lima, R.C. Lima & F. Goulart (2004) Cad. Saude Publica 20: 905-14.
15. Morisky, D.E., L.W. Green & D.M. Levine (1986) Med. Care 24: 67-74.
16. Sackett, D.L., R.B. Haynes, E.S. Gibson, B.C. Hackett, D.W. Taylor, R.S. Roberts et al. (1975) Lancet 305: 1205-7.
17. George, J., Y.T. Phun, M.J. Bailey, D.C. Kong & K. Stewart (2004) Ann. Pharmacother. 38: 1369-76.
18. Melchiors, A.C., C.J. Correr & F. Fernandez- Llimos (2007) Arq Bras Cardiol. 89: 210-8.
19. Yates, A.P. & I. Laing (2002) Diabetic Med. 19: 254-8.
20. Standl, E. (1999) Diabetes Obes. Metab 1 Suppl 2 S24-S36.
21. Silva, R.P., K. Cisne, J.M. De Oliveira, M. Kubrusly, C.R. Rodrigues Sobrinho & P.J. De Andrade (2008) Arq. Bras. Cardiol. 90: 99-103.
22. Carral San Laureano, F. (2000) Rev. Endocrinol. Nutr. 47: 108-12.
23. Lloyd, A., W. Sawyer & P. Hopkinson (2001) Value Health 4: 392-400.
24. Wexler, D.J., R.W. Grant, E. Wittenberg, J.L. Bosch, E. Cagliero, L. Delahanty et al. (2006) Diabetologia 49: 1489-97.
25. The Ukpds Group (1999) Diabetes Care 22: 1125-36.